Richard Vosser
Stock Analyst at J.P. Morgan
(3.36)
# 2,447
Out of 4,707 analysts
1232
Total ratings
50%
Success rate
2.2%
Average return
Main Sectors:
Stocks Rated by Richard Vosser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Maintained: Buy | 16,000p | 11,876p | +34.73% | 39 | Sep 7, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Buy | n/a | $111.80 | - | 121 | Sep 7, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €61.00 | €49.41 | +23.46% | 147 | Sep 3, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 275.00 | kr 292.00 | -5.82% | 158 | Sep 3, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | €950.00 | €869.20 | +9.30% | 4 | Aug 6, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €95.00 | €74.70 | +27.18% | 166 | Jul 31, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €295.00 | €238.10 | +23.90% | 75 | Jul 24, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €260.00 | €190.40 | +36.55% | 29 | Jul 24, 2026 | |
| EPA: IPN Ipsen S.A. | Maintained: Hold | n/a | $159.20 | - | 16 | Jun 29, 2026 | |
| ETR: MRK Merck KGaA | Maintained: Buy | €150.00 | €134.60 | +11.44% | 145 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 325.00 | CHF 350.50 | -7.28% | 191 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1,796.50 | - | 7 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $925 → $1,100 | $1,007.07 | +9.23% | 2 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €230.00 → €300.00 | €206.95 | +44.96% | 19 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 3.50 → CHF 3.00 | CHF 3.42 | -12.28% | 15 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $45.16 | - | 21 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $137.70 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 → $4 | $4.35 | n/a | 8 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €250.00 → €260.00 | €188.00 | n/a | 17 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 645.00 → CHF 650.00 | CHF 556.00 | n/a | 15 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €3.00 → €3.50 | €0.82 | n/a | 6 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $40 | $14.32 | n/a | 7 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €42.98 | €51.95 | n/a | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 3,000p | 1,596p | n/a | 7 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $176 | $38.10 | n/a | 1 | Mar 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $54.07 | n/a | 3 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $144 | $120.38 | n/a | 1 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $205 → $200 | $27.63 | n/a | 2 | Mar 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €185.00 | €24.08 | n/a | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | kr 1,150 | kr 2,170 | n/a | 1 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $33.53 | n/a | 1 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $43.16 | n/a | 1 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 | $7.75 | n/a | 1 | Jan 4, 2017 |
AstraZeneca PLC
Sep 7, 2026
Maintained: Buy
Price Target: 16,000p
Current: 11,876p
Upside: +34.73%
Novartis AG
Sep 7, 2026
Maintained: Buy
Price Target: n/a
Current: $111.80
Upside: -
Bayer Aktiengesellschaft
Sep 3, 2026
Maintained: Buy
Price Target: €61.00
Current: €49.41
Upside: +23.46%
Novo Nordisk A/S
Sep 3, 2026
Maintained: Hold
Price Target: kr 275.00
Current: kr 292.00
Upside: -5.82%
argenx SE
Aug 6, 2026
Maintained: Buy
Price Target: €950.00
Current: €869.20
Upside: +9.30%
Sanofi
Jul 31, 2026
Maintained: Hold
Price Target: €95.00
Current: €74.70
Upside: +27.18%
Sartorius Aktiengesellschaft
Jul 24, 2026
Maintained: Buy
Price Target: €295.00
Current: €238.10
Upside: +23.90%
Sartorius Stedim Biotech S.A.
Jul 24, 2026
Maintained: Buy
Price Target: €260.00
Current: €190.40
Upside: +36.55%
Ipsen S.A.
Jun 29, 2026
Maintained: Hold
Price Target: n/a
Current: $159.20
Upside: -
Merck KGaA
Jun 1, 2026
Maintained: Buy
Price Target: €150.00
Current: €134.60
Upside: +11.44%
May 1, 2026
Maintained: Hold
Price Target: CHF 325.00
Current: CHF 350.50
Upside: -7.28%
Dec 23, 2025
Maintained: Sell
Price Target: n/a
Current: $1,796.50
Upside: -
Dec 8, 2025
Maintained: Buy
Price Target: $925 → $1,100
Current: $1,007.07
Upside: +9.23%
Dec 8, 2025
Maintained: Buy
Price Target: €230.00 → €300.00
Current: €206.95
Upside: +44.96%
Dec 8, 2025
Maintained: Hold
Price Target: CHF 3.50 → CHF 3.00
Current: CHF 3.42
Upside: -12.28%
Nov 24, 2025
Maintained: Buy
Price Target: n/a
Current: $45.16
Upside: -
Nov 20, 2025
Maintained: Hold
Price Target: n/a
Current: $137.70
Upside: -
Sep 3, 2025
Maintained: Hold
Price Target: $4.5 → $4
Current: $4.35
Upside: n/a
Jul 22, 2025
Maintained: Buy
Price Target: €250.00 → €260.00
Current: €188.00
Upside: n/a
Dec 3, 2024
Maintained: Buy
Price Target: CHF 645.00 → CHF 650.00
Current: CHF 556.00
Upside: n/a
Dec 3, 2024
Maintained: Hold
Price Target: €3.00 → €3.50
Current: €0.82
Upside: n/a
Dec 5, 2023
Maintained: Hold
Price Target: $55 → $40
Current: $14.32
Upside: n/a
Jan 3, 2023
Upgraded: Buy
Price Target: €42.98
Current: €51.95
Upside: n/a
Sep 27, 2021
Maintained: Buy
Price Target: 3,000p
Current: 1,596p
Upside: n/a
Mar 18, 2021
Maintained: Buy
Price Target: $176
Current: $38.10
Upside: n/a
Dec 21, 2020
Maintained: Buy
Price Target: n/a
Current: $54.07
Upside: n/a
Jul 28, 2020
Maintained: Buy
Price Target: $144
Current: $120.38
Upside: n/a
Mar 2, 2020
Maintained: Hold
Price Target: $205 → $200
Current: $27.63
Upside: n/a
Jan 6, 2020
Downgraded: Hold
Price Target: €185.00
Current: €24.08
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: kr 1,150
Current: kr 2,170
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $33.53
Upside: n/a
Apr 11, 2017
Upgraded: Hold
Price Target: n/a
Current: $43.16
Upside: n/a
Jan 4, 2017
Upgraded: Buy
Price Target: $22
Current: $7.75
Upside: n/a